Swiss nanoinventory : results of the pilot study

Nanoparticles are particles smaller than 100nm in at least two dimensions. They are more and more used in novel industrial applications taking advantage of the new properties of this material. Therefore there is an urgent need to evaluate the risks of these particles to ensure their safe production, handling, use, and disposal, since a large number of different types of nanoparticles and applications are currently being developed and introduced into industrial processes and consumer products. Studies about type and quantity of industrially used manufactured nanoparticles and the exposure to them are insufficient in Switzerland. A qualitative telephone survey was conducted among two hundred Swiss companies to evaluate the nanoparticle applications in Swiss industries with regard to types and quantities of nanoparticles, protective measures and numbers of potentially exposed workers. Swiss companies were found applying the following nanoparticles in considerable quantities (tons per year): Ag, AlO3, Fe-Ox, SiO2, TiO2 and ZnO2. Applications were identified in the following fields: coating, cosmetics, food (animal feed, sport food and food packing), metal, optics, paintings, powder production, surface treatment, and research laboratories. This pilot study showed that nanoparticles are not fiction but already reality in the Swiss industry and it allowed an identification of industrial sectors with an established nanoparticle-use. It gave us valuable information about the knowledge of production and safety managers, and will form the basis for a detailed inventory, which eventually will be an essential element for the risk evaluation and prevention strategies regarding nanoparticles and health

Use of nanoparticles in Swiss industry: a targeted survey

A large number of applications using manufactured nanoparticles of less than 100 nm are currently being introduced into industrial processes. There is an urgent need to evaluate the risks of these novel particles to ensure their safe production, handling, use, and disposal. However, today we lack even rudimentary knowledge about type and quantity of industrially used manufactured nanoparticles and the level of exposure in Swiss industry. The goal of this study was to evaluate the use of nanoparticles, the currently implemented safety measures, and the number of potentially exposed workers in all types of industry. To evaluate this, a targeted telephone survey was conducted among health and safety representatives from 197 Swiss companies. The survey showed that nanoparticles are already used in many industrial sectors; not only in companies in the new field of nanotechnology, but also in more traditional sectors, such as paints. Forty-three companies declared to use or produce nanoparticles, and 11 imported and traded with prepackaged goods that contain nanoparticles. The following nanoparticles were found to be used in considerable quantities (> 1000 kg/year per company): Ag, Al-Ox, Fe-Ox, SiO2, TiO2, and ZnO. The median reported quantity of handled nanoparticles was 100 kg/year. The production of cosmetics, food, paints, powders, and the treatment of surfaces used the largest quantities of these nanoparticles. Generally, the safety measures were found to be higher in powder-based than in liquid-based applications. However, the respondents had many open questions about best practices, which points to the need for rapid development of guidelines and protection strategie

Effects of Stochastic Resonance Whole-Body Vibration in Individuals with Unilateral Brain Lesion: A Single-Blind Randomized Controlled Trial: Whole-Body Vibration and Neuromuscular Function

Introduction. Stochastic resonance whole-body vibration (SR-WBV) devices are promising sensorimotor interventions to address muscle weakness and to improve balance and mobility particularly in the elderly. However, it remains inconclusive whether individuals with stroke or traumatic brain injury (TBI) can profit from this method. The aim of this prospective single-blind randomized controlled trial was to investigate the effects of SR-WBV on muscle strength as well as gait and balance performance in this population. Methods. Forty-eight individuals with stroke or TBI were randomly allocated to an experimental and a sham group. Participants were exposed daily to 5 consecutives 1-minute SR-WBV sessions, whereas the experimental group trained in a standing position with 5 Hz and the sham group in a seated position with 1 Hz. Isometric muscle strength properties of the paretic knee extensor muscles as well as balance and gait performance were measured at baseline, after the first session and after two weeks of SR-WBV. Results. Both groups showed short- and long-term effects in gait performance. However, no between-group effects could be found at the three measurement points. Discussion. Complementary SR-WBV showed no beneficial effects immediately after the intervention and after two weeks of conventional rehabilitation therapy. Future research is needed to identify the potential efficacy of SR-WBV in individuals with stroke and TBI using shorter and less exhausting test procedures and a generally prolonged intervention time

Skilling up for training : a feasibility study investigating acute effects of stochastic resonance whole-body vibration on postural control of older adults

The present pilot study investigated the feasibility of applying a single bout stochastic resonance whole-body vibration in deconditioned elderly individuals and the effects on static and dynamic balance and reaction time. We report the results of a non-blinded randomized control trial with a pre-test/post-test design. Twenty elderly individuals were randomized into either single bout stochastic resonance whole-body vibration (SR-WBV) (n=10, frequency 5 Hz, Noise 4) or control (n=10). SR-WBV received 5 sets of 1 min stochastic whole-body vibration (5 Hz, Noise 4: vibration with a randomly varying frequency, 1=low, 4=high) with 1 min rest in between. The control group rested for 10 min without any intervention. Functional reach test (FRT), semi-tandem stand (STS), Expanded Timed Get Up-and-Go Test (ETGUG), single task- (ST) and dual task walking time (DT), chair rising (CR), and foot (RTF) and hand reaction time (RTH) were measured before and after the intervention. Within- and between group differences were analyzed using repeated measures. In order to assess the meaningfulness of pre-training to post-training changes, the effect size (ES) was calculated according to Cohen’s d. All participants in the study accepted and adhered to the WBV session and performed scheduled follow-up measurements. There were no adverse events. Change values for dynamic balance showed a strong trend towards improvement for FRT of about 4.5% (ES=0.52, P=0.161). Change values for RTF (5.9%; ES=0.55; P =0.169) showed a trend towards improvement in the SR-WBV only. The results suggest that stochastic resonance WBV is both safe and well accepted by elderly individuals in assisted living institutions, and might have beneficial effects on balance in these adults. Further research is warranted to determine whether this device might be of use in the skilling-up phase of an exercise program when training is initiated in strongly deconditioned and/or frail elderly. The new training protocol is expected to allow for safe skilling-up training of deconditioned older adults in assisted living institutions

A quantitative risk assessment for skin sensitizing plant protection products: Linking derived No-Effect levels (DNELs) with agricultural exposure models.

Chemical skin sensitizers produce allergic contact dermatitis, which is one of the most frequent occupational diseases associated with chemical exposures. Skin exposure is the major route of exposure when using plant protection products (PPPs). Therefore, skin sensitization is an important factor to be addressed during the regulatory risk assessment of PPPs. The main regulatory decision criterion considered when performing risk assessment for skin sensitizers is the dose applied. The equally important criteria "potency of the substance" is insufficiently considered by two potency categories as potency may vary up to five orders of magnitude. "Frequency of exposure" to the skin sensitizer is not considered at all. Consequently, an improved risk assessment methodology is essential to adequately assess health risks from skin sensitizers, especially for agricultural operators using PPPs. A quantitative risk assessment (QRA) approach for addressing PPPs sensitizing potential is proposed here. This QRA combines a methodology to derive a substance-specific threshold for skin sensitizers, a Derived No-Effect Level (DNEL), and an agricultural exposure model used for assessing chronic health risks of PPPs. The proposed QRA for skin sensitizing PPPs is a clear improvement over current risk assessment to ensure the safe use of skin sensitizers in an occupational context

Reviewing the environmental and human health knowledge base of carbon nanotubes.

Carbon nanotubes (CNTs) are considered one of the most promising materials in nanotechnology, with attractive properties for many technologic applications. The different synthesis, purification, and postprocessing methods produce CNTs with different physical characteristics, which can be applied in different fields ranging from composite materials, medical applications, and electronics to energy storage. The widespread projected use of CNTs makes it important to understand their potential harmful effects. In this environmental health review we observed a remarkable range of results of some of the toxicology studies. The comparability should be improved by further standardization and introduction of reference materials. However, at present the findings of this review suggest several key points: a) there are different types of CNTs, and therefore they cannot be considered a uniform group of substances; and b) in environmental compartments, CNTs can be bioavailable to organisms. The properties of CNTs suggest a possible accumulation along the food chain and high persistence. In organisms the absorption, distribution, metabolism, excretion, and toxicity of CNTs depend on the inherent physical and chemical characteristics such as CNT functionalization, coating, length, and agglomeration state that are influenced by the external environmental conditions during CNT production, use, and disposal stages. Characterized exposure scenarios could therefore be useful when conducting toxicologic studies. However, CNTs produce a toxic response upon reaching the lungs in sufficient quantity; this reaction is produced in a time-and dose-dependent manner. The identification of possible risks to human health and environment is a prerequisite for a successful introduction of CNTs in future applications

Nanopartikel am Arbeitsplatz

Nanopartikel sind sehr kleine Partikel, die gezielt so hergestellt sind, dass ihr Durchmesser kleiner als etwa 100 nm ist. Sie werden in der Industrie eingesetzt, weil Materialien mit solch kleinen Dimensionen oft neue Eigenschaften aufweisen, die sie vom Ursprungsmaterial unterscheidet. Das Potenzial für mögliche Gesundheits- und Umwelteffekte von Nanomaterialien wird zurzeit intensiv diskutiert, denn die möglichen Effekte der neuen Eigenschaften auf Umwelt und Gesundheit sind erst unvollständig geklärt. Für die Abklärung der Risiken ist es wichtig, Informationen über die möglichen Expositionen und mögliche Freisetzungen in die Umwelt zu haben. Bisher wurden aber Daten über eingesetzte Stoffmengen und Materialarten selten systematisch erhoben. Wir haben in der Schweiz eine repräsentative Studie durchgeführt, um den Einsatz von Nanopartikeln im gesamten Industriesektor abschätzen zu können. Diese Studie ist unseres Wissens weltweit die erste solche Studie. Sie verwendete die Definition von Nanopartikeln, welche Nanofasern und Agglomerate von Nanopartikeln mit einschließt. Geschätzte 1.300 Arbeiter in 600 Firmen sind direkt an einer Nanopartikelanwendung beteiligt und könnten somit exponiert werden. Dies sind etwa 0,6% der Firmen und etwa 0,08% der Arbeiter des Schweizer Produktionssektors. Um nun zu bestimmen, ob solche Arbeiter mit Nanopartikel in Kontakt kommen oder nicht, stehen verschiedene Messmethoden zur Verfügung. Die aktuelle Technik erlaubt eine quantitative Messung der Anzahl der Partikel in der Luft, deren Masse oder auch Oberfläche. Diese Messgrößen allein geben zwar Hinweise auf die Präsenz von Nanopartikeln, die möglichen Gesundheitseffekte einer Exposition sind aber erst unvollständig abgeklärt und erlauben keine abschließende Risikoanalyse für den Arbeitsplatz. Mehrere Aktionspläne für die Entwicklung eines sicheren und nachhaltigen Umgangs mit Nanomaterialien wurden in den letzten Jahren gestartet (EU, Schweiz). Internationale und nationale Organisationen entwickelten Guidelines und Empfehlungen für industrielle Anwendungen (Internationale Organisation für Normung - ISO, Schweizerische Unfallversicherungsanstalt - SUVA, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin - BAuA, zusammen mit dem Verband der Chemischen Industrie - VCI). Diese generellen Informationen müssen nun in die Industrie transferiert und an die spezifischen Bedürfnisse der betroffenen Unternehmen angepasst werden. Die aufgezeigte, relativ geringe Verbreitung von Nanopartikelanwendungen in der Industrie weist darauf hin, dass heute Schutzmaßnahmen noch proaktiv und kostengünstig entwickelt und eingeführt werden können. Aber sollte die vorhergesagte "Nano-Revolution" wirklich eintreten, ist die Zeit gekommen, jetzt aktiv zu werden. [Autoren]]]> Nanoparticles ; Industry ; Safety ; Data Collection ; Occupational Exposure ; Occupational Health ger https://serval.unil.ch/resource/serval:BIB_394A39C0520C.P001/REF.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_394A39C0520C4 info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_394A39C0520C4 info:eu-repo/semantics/submittedVersion info:eu-repo/semantics/openAccess Copying allowed only for non-profit organizations https://serval.unil.ch/disclaimer application/pdf oai:serval.unil.ch:BIB_394AB7B08ABD 2022-02-19T02:19:14Z <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> https://serval.unil.ch/notice/serval:BIB_394AB7B08ABD Der Fall aus der Praxis (276). Posttraumatischen Belastungsstorung. [A case from practice (276). Post-traumatic stress syndrome] info:eu-repo/semantics/altIdentifier/pmid/8378679 Haefliger, J. info:eu-repo/semantics/article article 1993-08 Schweizerische Rundschau fur Medizin Praxis, vol. 82, no. 35, pp. 949-51 info:eu-repo/semantics/altIdentifier/pissn/1013-2058 Accidents, Traffic/*psychology Adult Humans Male Stress Disorders, Post-Traumatic/*diagnosis/psychology oai:serval.unil.ch:BIB_394AE091D18F 2022-02-19T02:19:14Z openaire documents urnserval <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> https://serval.unil.ch/notice/serval:BIB_394AE091D18F Practicality of Acute and Transitional Care and its consequences in the era of SwissDRG: a focus group study. info:doi:10.1186/s12913-019-4220-0 info:eu-repo/semantics/altIdentifier/doi/10.1186/s12913-019-4220-0 info:eu-repo/semantics/altIdentifier/pmid/31196075 Wangmo, T. Padrutt, Y. Koné, I. Gächter, T. Elger, B.S. Leu, A. info:eu-repo/semantics/article article 2019-06-13 BMC health services research, vol. 19, no. 1, pp. 374 info:eu-repo/semantics/altIdentifier/eissn/1472-6963 urn:issn:1472-6963 <![CDATA[Switzerland recently introduced Acute and Transitional Care (ATC) as a new financing option and a preventive measure to mitigate potential side effects of Swiss Diagnosis Related Group (SwissDRG). The goal of ATC was to support patients who after acute treatment at a hospital require temporary increased professional care. However, evidence is lacking as to the practicality of ATC. Using qualitative focus group methodology, we sought to understand the implementation and use of ATC. A purposive sample of forty-two professionals from five Swiss cantons participated in this study. We used a descriptive thematic approach to analyse the data. Our findings first reveal that ATC's implementation differs in the five cantons (i.e. federal states). In two cantons, only ambulatory variant of ATC is used; in one canton only stationary ATC has been created, and two cantons had both ambulatory and stationary ATC but preferred the latter. Second, there are intrinsic practical challenges associated with ATC, which include physicians' lack of familiarity with ATC and its regulatory limitations. Finally, participants felt that due to shorter hospital stays because of SwissDRG, premature discharge of patients with complex care needs to stationary ATC takes place. This development does not fit the nursing home concept of care tailored to long-term patients. This empirical study underscores that there is a strong need to improve ATC so that it is uniformly implemented throughout the country and its application is streamlined. In light of the newness of ATC as well as SwissDRG, their impact on the quality of care received by patients is yet to be fully understood. Empirical evidence is necessary to improve these two measures

Nanoparticle usage and protection measures in the manufacturing industry : a representative survey

Addressing the risks of nanoparticles requires knowledge about release into the environment and occupational exposure. However, such information currently is not systematically collected; therefore, this risk assessment lacks quantitative data. The goal was to evaluate the current level of nanoparticle usage in Swiss industry as well as health, safety, and environmental measures, and the number of potentially exposed workers. A representative, stratified mail survey was conducted among 1626 clients of the Swiss National Accident Insurance Fund (SUVA), which insures 80,000 manufacturing firms, representing 84% of all Swiss manufacturing companies (947 companies answered the survey for a 58.3% response rate). The extrapolation to all Swiss manufacturing companies results in 1309 workers (95% confidence interval [CI]: 1073 to 1545) potentially exposed to nanoparticles in 586 companies (95% CI: 145 to 1027). This corresponds to 0.08% of workers (95% CI: 0.06% to 0.09%) and to 0.6% of companies (95% CI: 0.2% to 1.1%). The industrial chemistry sector showed the highest percentage of companies using nanoparticles (21.2%). Other important sectors also reported nanoparticles. Personal protection equipment was the predominant protection strategy. Only a few applied specific environmental protection measures. This is the first nationwide representative study on nanoparticle use in the manufacturing sector. The information gained can be used for quantitative risk assessment. It can also help policymakers design strategies to support companies developing a safer use of nanomaterial. Notingthe current low use of nanoparticles, there is still time to proactively introduce protective methods. If the predicted "nano-revolution" comes true, now is the time to take action. [Supplementary materials are available for this article. Go to the publisher's online edition of Journal of occupational and Environmental Hygiene for the following free supplemental resource: a pdf file containing a detailed description of the approach to statistical analyses, English translation of the questionnaire, additional information for Figure 1, and additional information for the SUVA-code.] [Authors]]]> Data Collection ; Environmental Monitoring ; Humans ; Industry ; Nanoparticles ; Occupational Exposure ; Policy Making ; Protective Devices ; Risk Assessment ; Workplace eng https://serval.unil.ch/resource/serval:BIB_3A09102817F4.P001/REF.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3A09102817F43 info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3A09102817F43 info:eu-repo/semantics/acceptedVersion info:eu-repo/semantics/openAccess Copying allowed only for non-profit organizations https://serval.unil.ch/disclaimer application/pdf oai:serval.unil.ch:BIB_3A0928641E8F 2022-02-19T02:19:18Z openaire documents urnserval <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> https://serval.unil.ch/notice/serval:BIB_3A0928641E8F Pneumopathie d'hypersensibilité Lazor, R. Olgiati, R. info:eu-repo/semantics/article article 2011 VivO2 spécial, no. 5, pp. 14-15 fre https://serval.unil.ch/resource/serval:BIB_3A0928641E8F.P001/REF.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3A0928641E8F2 info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3A0928641E8F2 info:eu-repo/semantics/submittedVersion info:eu-repo/semantics/openAccess Copying allowed only for non-profit organizations https://serval.unil.ch/disclaimer application/pdf oai:serval.unil.ch:BIB_3A0953F50D55 2022-02-19T02:19:18Z openaire documents <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> https://serval.unil.ch/notice/serval:BIB_3A0953F50D55 Automation of RNA-based biomarker extraction from dried blood spots for the detection of blood doping. info:doi:10.4155/bio-2020-0041 info:eu-repo/semantics/altIdentifier/doi/10.4155/bio-2020-0041 info:eu-repo/semantics/altIdentifier/pmid/32412781 Loria, F. Manfredi, M. Reverter-Branchat, G. Segura, J. Kuuranne, T. Leuenberger, N. info:eu-repo/semantics/article article 2020-06 Bioanalysis, vol. 12, no. 11, pp. 729-736 info:eu-repo/semantics/altIdentifier/eissn/1757-6199 urn:issn:1757-6180 <![CDATA[Aim: Transcriptomic biomarkers originating from reticulocytes measured in dried blood spots (DBSs) may be reliable indicators of blood doping. Methods/results: Here, we examined changes in the expression levels of the erythropoiesis-related ALAS2, CA1 and SLC4A1 genes in DBS samples from elite athletes and volunteers of clinical study with recombinant erythropoietin dose. Conclusion: By comparing the mean intraday coefficients of variation for ALAS2L, ALASLC, CA1 and SLC4A1 between manual and automated RNA extractions, an average improvement was observed, whereas the assessment of interday variability provided comparable results for both manual and automated approaches. Our results confirmed that RNA biomarkers on DBS support are efficient to detect blood doping